Pfizer completes acquisition of Icagen
28 October 2011 | By Pfizer
Pfizer Inc. has completed its acquisition of Icagen, Inc., through the merger of its wholly owned subsidiary, Eclipse Acquisition Corp., with and into Icagen...
List view / Grid view
28 October 2011 | By Pfizer
Pfizer Inc. has completed its acquisition of Icagen, Inc., through the merger of its wholly owned subsidiary, Eclipse Acquisition Corp., with and into Icagen...
22 January 2020 | By Victoria Rees (European Pharmaceutical Review)
The pharmaceutical industry saw some notable mergers and acquisitions in 2019; this article lists the top 10 by transaction size.
1 March 2011 | By Pfizer
Pfizer completed its acquisition of King through the merger of its wholly owned subsidiary, Parker Tennessee Corp...
7 April 2014 | By Daiichi Sankyo
Pursuant to the merger transaction announced between Ranbaxy Laboratories Limited and Sun Pharmaceutical Industries Ltd. announces that it has agreed to vote its shares in Ranbaxy in favor of Sun Pharma’s acquisition of 100%...
22 November 2019 | By European Pharmaceutical Review
After regulatory approval, Bristol-Myers Squibb has announced its successful acquisition of Celgene, completing the merger.
11 April 2014 | By Daiichi Sankyo
As announced in a release dated April 7, 2014, pursuant to a merger transaction, whereby Daiichi Sankyo Company, Limited has agreed with Sun Pharmaceutical Industries Ltd...
28 May 2021 | By Hannah Balfour (European Pharmaceutical Review)
The UK’s competition authority will assess whether AstraZeneca’s acquisition of Alexion will result in a “substantial lessening of competition”.
2 May 2023 | By Catherine Eckford (European Pharmaceutical Review)
A $5.9 billion acquisition of biotech Iveric Bio by Astellas is set to accelerate development of treatments for blinding retinal diseases.
5 February 2024 | By Catherine Eckford (European Pharmaceutical Review)
As part of its acquisition of Catalent, Novo Holdings plans to sell three Catalent fill-finish sites, supporting the growth of the European and US manufacturing capacity.
26 August 2014 | By Roche
Roche and InterMune, Inc. announced they have entered into a definitive merger agreement for Roche to fully acquire InterMune at a price of US$ 74.00 per share in an all-cash transaction...
5 August 2015 | By Victoria White
The ECs has approved Pfizer’s pending acquisition of Hospira - a transaction that will greatly expand Pfizer's sterile injectable pharmaceuticals portfolio...
8 April 2011 | By Sanofi-Aventis
Sanofi-aventis has announced that it has completed its acquisition of Genzyme Corporation...
20 June 2012 | By AstraZeneca
AstraZeneca has completed its acquisition of San Diego, California-based biotechnology company Ardea Biosciences, Inc...
3 August 2012 | By GlaxoSmithKline
GlaxoSmithKline has completed its acquisition of Human Genome Sciences for US$3.6 billion...
16 November 2022 | By Catherine Eckford (European Pharmaceutical Review)
Indivior’s $145 million acquisition of Opiant Pharmaceuticals will support the launch of OPNT003, an opioid overdose reversal agent.